Current calls, week 5, 2023
Tips from Grants Office regarding current calls
Swedish and Nordic calls
Dermatology Research Grants – LEO Foundation
The foundation welcomes applications for research projects that improve the understanding of skin biology as well as the underlying medicinal, biological, chemical, or pharmacological mechanisms of dermatological diseases and their symptoms. It also welcomes applications for projects that address clinical issues among people who are at risk of developing, or have developed, a skin disease, including how it impacts their quality of life and the societal costs involved. The foundation does not currently support projects on skin cancer, however, skin cancer models may be permitted if used as tools to investigate other aspects of skin or skin diseases.
Closing date: February 28, 2023
Pioneer Innovator Grant Sustainability and Health – Novo Nordisk Foundation
The purpose of the grant is to accelerate the commercialisation of research findings and the development of novel technologies within sustainability or health. Both areas of the Pioneer Innovator Grants seek to support novel academic science-based discoveries with commercial potential. The grant aims to stimulate the evaluation of ideas and to support experiments and activities leading to proof-of-concept or beyond.
The Pioneer Innovator Grant Health seeks to support innovative research within med-tech, industrial biotech, or pharma, and to stimulate the evaluation of ideas that for example could lead to the development of new medical treatment, disease prevention, diagnostic methods as well as new health technologies, devices and technological platforms. Particular focus will be placed on projects covering cardiometabolic diseases as well as infectious diseases and preventive solutions hereto. Projects must be directly linked to improving the lives of patients and health of people.
Closing date: March 9 , 2023
- Gästforskarstipendier: avsedda att underlätta för utländska seniora forskare att verka i Sverige. Sökes av svensk forskare som är värd för utländsk forskare.
- Sabbatsstipendier: avsedda att möjliggöra för svensk senior forskare, vanligen professor, att verka vid utländsk vetenskaplig institution
- Resestipendier: avsedda för kortare tids besök utomlands för aktivt deltagande i internationella kongresser, symposier, workshops och kurser. Medel ges inte för forskningsvistelser utomlands
- Symposier: anslagen är avsedda som bidrag till organiserandet av internationella symposier som hålls i Sverige.
Closing date: March 10, 2023
Prince Daniel's research grant for promising junior researchers – Swedish Heart-Lung Foundation
These support the new generation of junior researchers. The grant is worth up to SEK 6 million over three years.
Closing date: March 14, 2023
Conference grants - the Swedish Research Council for Health, Working Life and Welfare (Forte)
Grants give financial support for holding conferences, primarily national ones held in Sweden, with international elements. Conference should facilitate contacts and exchange of experience between researchers, add knowledge from the national or international research community, and contribute to the dissemination of Swedish research. Conferences should be hosted by a Swedish institution of higher education or scientific/scholarly organization.
This is an organizational call for applications. Please contact Grants Office, firstname.lastname@example.org, for information regarding the application procedure.
The maximum grant amount is SEK 300,000.
Closing date: March 15, 2023.
Starting grants 2023 - Swedish Research Council for Health, Working Life and Welfare (Forte)
Forte announces a starting grant replacing the national and international postdoc grants. The grant is aimed at researchers in the beginning of their research career, with the purpose of promoting establishment and independence in research.
A maximum of SEK 1,25 million per year can be applied for the period of up-to three years. The dedicated time for the project must be at least 50 percent of full time.
Closing date: March 21, 2023
Forsknings- och utvecklingsprojekt inom hälsa - AFA Försäkring
AFA Försäkring annonserar utlysningar inom området hälsa med fokus på arbetsförmåga inom områden:
Behandlingsformer och metoder; Sjukfrånvaro; Rehabilitering; Sjukdomsförebyggande insatser. Forskningen ska syfta till att behålla och stärka arbetsförmåga för att förkorta sjukfrånvaron i arbetslivet.
Satsningen ska finansiera forskning som förväntas ge konkreta effekter i en nära framtid, resultat från nya projekt som finansieras inom området ska kunna komma till nytta inom fem år.
Closing date: March 21, 2023
ERC Advanced Grants 2023 call
On December 8th, 2022, the European Research Council (ERC) opened its call for applications for ERC Advanced Grants 2023. These support ground-breaking, high-risk high-gain projects carried out by an established, leading principal investigator in any field of research. Applicants are expected to be active researchers who have a track record of significant research achievements in the last 10 years and should be exceptional leaders in terms of originality and significance of their research contributions.
Each grant is worth up to €2.5m over five years. An additional €1m may be requested.
Submission deadline: 23/05/2023
Please contact Grants Office if you are interested in applying with KI as host institution (email@example.com)
Register for the VR webinar on ERC Advanced Grant 2023 on 10 February 2023.
• ERC Advanced Grants official web page -- Who can apply and with what type of project?
• Information for Applicants_ERC_AdG_2023
• KI ERC web pages -- Applying for an ERC grant with KI as Host Institution
Research unit – European Society for Paediatric Endocrinology (ESPE)
The ESPE Research Unit is a collaborative research grant which aims to foster, facilitate, coordinate, and identify topics for high-quality research in paediatric endocrinology, for both physicians and scientists.
Members of ESPE may apply. Each application must include at least one principal investigator and two co-investigators who are ESPE members. Non-ESPE members may participate as additional co-investigators. Applications that consist of investigators from at least three different countries are encouraged.
One large grant is available annually. The large grant is worth €100,000 for a period of two years.
Deadline: Preliminary applications due by 15 February 2023; full applications due by 20 April 2023.
Career Research Grants -- Foundation for Research in Rheumatology (FOREUM)
These enable young researchers to conduct basic and clinical science projects related to rheumatic and musculoskeletal diseases (RMD). The aim is to foster independent science and develop new research leaders in the field.
Young scientists with an already existing track record in RMD research may apply. They must hold an MD or PhD that was awarded no longer than eight years ago, parental leave excluded, and be appropriately linked to RMD research in Europe. Participation of patient research partners is strongly encouraged.
Deadline: letter of intent due 19 Feb 2023; full proposal due 23 April 2023
Practical courses -- European Molecular Biology Organisation (EMBO)
Funding supports the organisation of courses that promote the transfer of new methods and emerging techniques in life science-related areas, and to enable participating students to implement novel techniques in their home laboratories.
Practical courses are limited to between 20 and 25 participants, excluding speakers, who are usually early-stage postdoctoral researchers and advanced PhD students. The courses may take place in EMBC member states, associated member states or cooperating partner countries, although organisers may be based anywhere.
The maximum funding available for practical courses is €39,000
Deadline: 1 March 2023 and 1 August 2023
EFSD/Sanofi European diabetes research programme in diabetes associated with cardiovascular disease – EFSD/Sanofi
This supports European research aimed at improving understanding of cardiovascular disease associated with diabetes. Grants are offered for basic and clinical studies. Translational studies are especially welcome. Studies forming part of a larger project will be considered for funding, but this will need to be well justified.
The duration of each award may be one year or longer, depending upon the needs of the project and as justified in the application. Single non-profit institutions or groups of such institutions from Europe and associated countries may apply.
Max. grant amount is 100 000 Euros.
Deadline: 15 March 2023
Federal Funding agencies
BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed): NIH
The purpose of this Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative is to encourage research that will develop and validate novel tools to facilitate the detailed analysis of complex circuits and provide insights into cellular interactions that underlie brain function. The new tools and technologies should inform and/or exploit cell-type and/or circuit-level specificity. Plans for validating the utility of the tool/technology will be an essential feature of a successful application. The development of new genetic and non-genetic tools for delivering genes, proteins and chemicals to cells of interest or approaches that are expected to target specific cell types and/or circuits in the nervous system with greater precision and sensitivity than currently established methods are encouraged. Tools that can be used in a number of species/model organisms rather than those restricted to a single species are highly desired. Applications that provide approaches that break through existing technical barriers to substantially improve current capabilities are highly encouraged.
Deadline: June 7, 2023. Applications are due by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): RFA-MH-21-175
Innovative Research in Cancer Nanotechnology (IRCN) (R01 Clinical Trial Not Allowed): NIH
This Funding Opportunity Announcement (FOA) entitled "Innovative Research in Cancer Nanotechnology (IRCN)" encourages applications promoting transformative discoveries in cancer biology and/or oncology through the use of nanotechnology. Proposed projects should address major barriers in cancer biology and/or oncology using nanotechnology and should focus on mechanistic studies to expand the fundamental understanding of nanomaterial and/or nano-device interactions with biological systems. These studies are expected to be relevant to the delivery of nanoparticles and/or nano-devices to desired and intended cancer targets in vivo and/or characterization of detection and diagnostic devices and sensors in vitro. IRCN awards are expected to produce fundamental knowledge to aid future and more informed development of nanotechnology-based cancer interventions.
Deadline: May 4, 2023. Applications are due by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): PAR-20-284
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional): NIH
Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) encourages the submission of exploratory/developmental research grant (R21) applications that focus on different aspects of cancer control by modifying behavior, screening, and understanding etiologic factors contributing to the development of cancer, and developing ways to control cancer. The overarching goal is to provide support to promote the early and conceptual stages of research efforts on novel scientific ideas that have the potential to substantially advance population-based cancer research, such as the development of novel techniques, agents, interventions, methodologies, models, or applications that could have a major impact on a field of cancer research (e.g. epidemiologic, biomedical, behavioral, health care delivery or clinical).
Deadline: June 7, 2023. Applications are due by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): PAR-21-341
Research Grant, amfAR, US
amfAR’s research initiatives are aimed at finding a cure for HIV that will be useful to the 38M people living with HIV. The urgency of our goal demands that we direct our funding to studies that uncover vital knowledge directly applicable to curing HIV. amfAR aims to support research projects focused on curing HIV. Proposals should be interventional:
- The intervention must take place in any in vivo model including people with HIV, non-human primates, or humanized mice, or ex vivo in cells taken from PWH. An intervention tested only in cell lines, or ex vivo in animal cells, does not meet the criteria for this RFP.
- Submissions that propose only describing the reservoir (i.e. no intervention) will not be forwarded for review.
- Specific aims that are descriptive, within a submission that includes an intervention, may be cut by amfAR if the descriptive work does not pertain to changes to the reservoir in response to the intervention.
amfAR’s preference is for interventions that eliminate infected cells or provirus, rather than those that provide for ART-free control of persisting virus.
Eligibility: HIV researchers holding a doctoral degree and affiliated with a nonprofit research institute.
Budget: Type 1: Up to $100,000 direct costs, plus up to 20% indirect costs. One-year duration starting July 1, 2023. Type 2: up to $400,000 direct costs, plus up to 20% indirect costs. Up to two years duration starting July 1, 2023
Deadline: 14th March, 2023.
2023 Rising Tide/LUNGevity Team Award Program, LUNGevity, US
The Rising Tide/LUNGevity Team Award Program to Target Mechanisms of Resistance Award funds high-impact research that seeks to develop therapeutic strategies targeting shared mechanisms of resistance in oncogene-driven lung adenocarcinoma. The research project(s) that will be funded are expected to further our knowledge of shared mechanisms of resistance across oncogene-driven lung adenocarcinoma (LUAD) and how they can be targeted using novel pharmaceutical agents (monotherapies or combination therapies).
Eligibility: Have a faculty appointment and have completed postdoctoral training. This is a team award and at least two institutions are required to be involved.
Budget: The award will be funded at a maximum of $1,500,000 for up to three years. Overhead/indirect costs are not permitted.
Deadline: LOI - 27th February, 2023; full application (by invitation) - 8th May, 2023.
Research Grants, Alzheimer’s Association, US
Sex and Gender in Alzheimer's (SAGA 23). Building off the 2017 SAGA program and the continued investment by the Alzheimer's Association, the SAGA-23 funding program will aim to fund projects to directly advance the understanding and fill in gaps in knowledge of the contribution of sex, gender, and gender identity contributions to AD/ADRD.
Eligibility: Postdoctoral researchers, researchers with full-time staff or faculty appointments (Assistant Professor and above). Overlapping funding of more than one Alzheimer's Association grant is not allowed.
Budget: The budget must not exceed $100,000 in any given year (direct and indirect costs) nor exceed $250,000 total across all years, including indirect costs. The minimum duration of award is 18 months and the maximum duration is up to 3 years – awards cannot be for only one year. No more than 10% of the total award may be used for indirect costs.
Deadline: LOI - 15th February, full application - 26th April.
Alzheimer's Association Research Fellowship (AARF). The AARF grant program is intended to support exceptional researchers who are engaged in their post-graduate work (i.e. postdoctoral fellows) and before they have their first independent faculty positions (i.e. Assistant Professor) and working in diverse areas of research, including basic, translational, clinical, functional and social-behavioral research. Investigators doing clinically-focused research without clinical practice are encouraged to apply. Note: AA also offers a Fellowship directed towards clinicians (AACSF), more details on their website.
Eligibility: Individuals applying must have less than 13 years of research experience after receipt of their doctorate or other terminal degree. Individuals who have a position of an Assistant Professorship or above are not eligible.
Budget: Each Fellowship award is limited to $200,000. Indirect costs are capped at 10 percent of total direct costs.
Deadline: LOI - 6th March, full application - 4th May.
Alzheimer's Association Research Grant (AARG). The AARG grant program aims to fund early-career investigators who are less than 18 years past their doctoral degree or post-residency (M.D. or D.O.) with funding that will allow them to develop preliminary or pilot data, to test procedures and to develop hypotheses. The intent is to support early-career development that will lay the groundwork for future research grant applications to federal or other funding entities. Note: AA also offers research grants directed towards researchers entering the field of dementia research from other area (AARG-NTF), see website for details.
Eligibility: Applicants must be an Assistant Professor or Associate Professor at their respective academic institution and less than 18 years past their doctoral degree or post-residency (M.D. or D.O.).
Budget: Each AARG award total is limited to $200,000 (direct and indirect costs) for up to three years. Awards should be a minimum 2 years. Indirect costs are capped at 10 percent of total direct costs.
Deadline: LOI - 6th March, full application - 4th May.
AACR Cancer Disparities Research Fellowship, American Association for Cancer Research, US
The AACR Cancer Disparities Research Fellowship represents an effort to encourage and support postdoctoral or clinical research fellows to conduct cancer disparities research and to establish a successful career path in this field. The proposed research may be in basic, translational, clinical, or population sciences and must have direct applicability and relevance to cancer disparities.
Eligibility: Applicants must have completed their most recent doctoral degree within the past five years (i.e., degree cannot have been conferred before July 1, 2018; the formal date of receipt of doctoral degree is the date the degree was conferred, as indicated on their diploma and/or transcript).
Budget: The fellowship provides a two-year grant of $120,000 to support the salary and benefits of the fellow while working on mentored cancer disparities research. Indirect costs are not allowable.
Deadline: 23rd March, 2023.